|
|
Heart. 1997 October; 78(4): 337–342. | PMCID: PMC1892250 |
Restenosis after elective coronary balloon angioplasty in patients with end stage renal disease: a case-control study using quantitative coronary angiography F. Schoebel, F. Gradaus, K. Ivens, P. Heering, T. W. Jax, B. Grabensee, B. Strauer, and M. Leschke Medizinische Klinik, Heinrich-Heine Universität Düsseldorf, Germany. Email: Frank-Chris.Schoebel/at/uni-duesseldorf.de Objective—To assess the rate of angiographic restenosis in patients with end stage renal disease after elective coronary angioplasty.
Design—A retrospective case-control study of 20 patients with end stage renal disease and 20 sex and age matched controls without renal disease, who had undergone primarily successful coronary angioplasty. Control coronary angiography was performed regardless of worsening or renewed incidence of anginal symptoms.
Main outcome measures—Group comparison of coronary morphology, as evaluated by quantitative coronary angiography, and of cardiovascular risk factors.
Results—The rate of angiographic restenosis was 60% in patients with renal disease and 35% in controls. In patients with end stage renal disease the following differences (mean (SD) were found versus controls: raised plasma fibrinogen (483 (101) v 326 (62) mg/dl, p < 0.001); raised plasma triglyceride (269 (163) v 207 (176) mg/dl, p < 0.01); smaller diameter of the coronary reference segment (2.59 (0.87) v 2.90 (0.55) mm, p < 0.10); smaller minimum luminal diameter of the dilated stenosis (0.77 (0.46) v 0.97 (0.27) mm, p < 0.05). Discriminant analysis showed that minimum luminal diameter before angioplasty (r = −0.79) and fibrinogen (r = +0.34) had the highest statistical association with restenosis.
Conclusions—The high rate of angiographic restenosis in patients with end stage renal disease seems to be related to the size of the vessel dilated and to an increased prothrombotic risk, as indicated by higher fibrinogen concentrations.
Keywords: renal disease; coronary artery disease; coronary angioplasty; restenosis The Full Text of this article is available as a PDF (126K). These references are in PubMed. This may not be the complete list of references from this article. - Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974 Mar 28;290(13):697–701. [PubMed]
- Hellerstedt WL, Johnson WJ, Ascher N, Kjellstrand CM, Knutson R, Shapiro FL, Sterioff S. Survival rates of 2,728 patients with end-stage renal disease. Mayo Clin Proc. 1984 Nov;59(11):776–783. [PubMed]
- Gokal R, Jakubowski C, King J, Hunt L, Bogle S, Baillod R, Marsh F, Ogg C, Oliver D, Ward M, et al. Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study. Lancet. 1987 Nov 14;2(8568):1105–1109. [PubMed]
- Raine AE, Margreiter R, Brunner FP, Ehrich JH, Geerlings W, Landais P, Loirat C, Mallick NP, Selwood NH, Tufveson G, et al. Report on management of renal failure in Europe, XXII, 1991. Nephrol Dial Transplant. 1992;7 Suppl 2:7–35. [PubMed]
- Salerno DM, Granrud G, Sharkey P, Asinger R, Hodges M. A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes. Am J Cardiol. 1984 Jan 1;53(1):77–83. [PubMed]
- Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi H, Ohishi H. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol. 1988 Sep;12(3):616–623. [PubMed]
- Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, Reiber JH, ten Katen HJ, van Es GA, Hugenholtz PG. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation. 1988 Feb;77(2):361–371. [PubMed]
- Ahmed WH, Shubrooks SJ, Gibson CM, Baim DS, Bittl JA. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients. Am Heart J. 1994 Aug;128(2):252–255. [PubMed]
- Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO. Short- and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients. Am Heart J. 1990 Mar;119(3 Pt 1):484–489. [PubMed]
- Rinehart AL, Herzog CA, Collins AJ, Flack JM, Ma JZ, Opsahl JA. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients. Am J Kidney Dis. 1995 Feb;25(2):281–290. [PubMed]
- CLAUSS A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957 Apr;17(4):237–246. [PubMed]
- Ambrose JA, Winters SL, Arora RR, Eng A, Riccio A, Gorlin R, Fuster V. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol. 1986 Mar;7(3):472–478. [PubMed]
- Herrington DM, Siebes M, Sokol DK, Siu CO, Walford GD. Variability in measures of coronary lumen dimensions using quantitative coronary angiography. J Am Coll Cardiol. 1993 Oct;22(4):1068–1074. [PubMed]
- Leschke M, Blanke H, Stellwaag M, Motz W, Strauer BE. Hyperfibrinogenämie und pathologische Plasmaviskosität. Pathogenetische Faktoren bei der instabilen Angina pectoris? Dtsch Med Wochenschr. 1988 Jul 29;113(30):1175–1181. [PubMed]
- Leschke M, Schoebel FC, Mecklenbeck W, Stein D, Jax TW, Müller-Gärtner HW, Strauer BE. Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial. J Am Coll Cardiol. 1996 Mar 1;27(3):575–584. [PubMed]
- Ceriello A, Pirisi M, Giacomello R, Stel G, Falleti E, Motz E, Lizzio S, Gonano F, Bartoli E. Fibrinogen plasma levels as a marker of thrombin activation: new insights on the role of fibrinogen as a cardiovascular risk factor. Thromb Haemost. 1994 May;71(5):593–595. [PubMed]
- Stein D, Heins M, Schoebel FC, Pels K, Jax TW, Stiegler H, Reinauer H, Strauer BE, Leschke M. Activation of the fibrinolytic system in patients with coronary artery disease and hyperfibrinogenemia. Thromb Haemost. 1997 May;77(5):970–974. [PubMed]
- Gris JC, Branger B, Vécina F, al Sabadani B, Fourcade J, Schved JF. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients. Kidney Int. 1994 Sep;46(3):807–813. [PubMed]
- Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood. 1987 Aug;70(2):343–350. [PubMed]
- Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci PM, Rosenberg RD. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation. 1994 Jul;90(1):61–68. [PubMed]
- Leimgruber PP, Roubin GS, Hollman J, Cotsonis GA, Meier B, Douglas JS, King SB, Jr, Gruentzig AR. Restenosis after successful coronary angioplasty in patients with single-vessel disease. Circulation. 1986 Apr;73(4):710–717. [PubMed]
- Quigley PJ, Hlatky MA, Hinohara T, Rendall DS, Perez JA, Phillips HR, Califf RM, Stack RS. Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis. Am J Cardiol. 1989 Feb 15;63(7):409–413. [PubMed]
- Fuster V, Falk E, Fallon JT, Badimon L, Chesebro JH, Badimon JJ. The three processes leading to post PTCA restenosis: dependence on the lesion substrate. Thromb Haemost. 1995 Jul;74(1):552–559. [PubMed]
- Shah PK, Amin J. Low high density lipoprotein level is associated with increased restenosis rate after coronary angioplasty. Circulation. 1992 Apr;85(4):1279–1285. [PubMed]
- Koch M, Gradaus F, Schoebel FC, Leschke M, Grabensee B. Relevance of conventional cardiovascular risk factors for the prediction of coronary artery disease in diabetic patients on renal replacement therapy. Nephrol Dial Transplant. 1997 Jun;12(6):1187–1191. [PubMed]
- Brown BG, Hillger LA, Lewis C, Zhao XQ, Sacco D, Bisson B, Fisher L. A maximum confidence approach for measuring progression and regression of coronary artery disease in clinical trials. Circulation. 1993 Mar;87(3 Suppl):II66–II73. [PubMed]
- Schwarz F, Preusler W, Reifart N, Störger H, Baier T, Schlotzer P, Neubauer A, Heinsen S. Langzeiterfolg nach Koronarangioplastie in Abhängigkeit von der Gefässgrösse. Dtsch Med Wochenschr. 1991 Dec 6;116(49):1857–1861. [PubMed]
- Hirshfeld JW, Jr, Schwartz JS, Jugo R, MacDonald RG, Goldberg S, Savage MP, Bass TA, Vetrovec G, Cowley M, Taussig AS, et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators. J Am Coll Cardiol. 1991 Sep;18(3):647–656. [PubMed]
- Amann K, Neusüss R, Ritz E, Irzyniec T, Wiest G, Mall G. Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens. 1995 Apr;8(4 Pt 1):409–417. [PubMed]
- Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease. Circulation. 1995 Oct 15;92(8):2333–2342. [PubMed]
- Farb A, Virmani R, Atkinson JB, Anderson PG. Long-term histologic patency after percutaneous transluminal coronary angioplasty is predicted by the creation of a greater lumen area. J Am Coll Cardiol. 1994 Nov 1;24(5):1229–1235. [PubMed]
- Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation. 1992 Dec;86(6 Suppl):III47–III52. [PubMed]
- Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990 Jun;15(7):1667–1687. [PubMed]
- Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 1994 Aug 25;331(8):496–501. [PubMed]
- Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 1994 Aug 25;331(8):489–495. [PubMed]
|
This article has been